|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.6 TWD | +0.13% |
|
+0.79% | -4.73% |
| Mar. 14 | TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 08 | TTY Biopharm Company Limited Announces Change of CFO and Financial Officer | CI |
TTY Biopharm Company Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 1,166.33 million compared to TWD 1,037.11 million a year ago. Net income was TWD 238.68 million compared to TWD 227.51 million a year ago.
Basic earnings per share from continuing operations was TWD 0.96 compared to TWD 0.91 a year ago. Diluted earnings per share from continuing operations was TWD 0.96 compared to TWD 0.91 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.73% | 584M | |
| +25.83% | 661B | |
| +26.67% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.77% | 231B | |
| +5.24% | 200B | |
| -8.79% | 195B | |
| -6.26% | 145B |
TTY BIOPHARM COMPANY LIMITED 
